Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose

Pharmacology and Toxicology

Volumn 78, Issue 6, 1996, Pages 417-420

  Mamzoridi, Katerina ^a   Kasteridou, Nicoletta ^a   Peonides, Alexander ^a   Niopas, Loannis ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CEFIXIME; CEFTORAL; UNCLASSIFIED DRUG;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG URINE LEVEL; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; SCHOOL CHILD; URINARY EXCRETION; URINARY TRACT INFECTION;

EID: 0029948997     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb00229.x     Document Type: Article

References (16)

1. Britain, D. C., B. E. Scully, T. Hirose & H. C. Neu: The pharmacokinetic and bactericidal characteristics of oral cefixime. Clin. Pharmacol. Therap. 1985, 38, 590-594.
2. Dhib, M., B. Moulin, A. Leroy, B. Hameau, M. Godin, R. Johannides & J. P. Fillastre: Relationship between renal function and disposition of oral cefixime. Eur. J. Clin. Pharmacol. 1991, 41, 579-583.
3. Faulkner, R. D., W. Bohaychuk, R. E. Desjardins, Z. M. Look, J. D. Haynes, A. I. Weiss & B. M. Silber: Pharmacokinetics of cefixime after once-a-day and twice-a-day dosing to steady-state. J. Clin. Pharmacol. 1987a, 27, 807-812.
4. Faulkner, R. D., A. Yacobi, J. S. Barone, S. A. Kaplan & B. M. Silber: Pharmacokinetic profile of cefixime in man. Pediatr. Infect. Dis. J. 1987b, 6, 963-970.
5. Faulkner, R. D., L. L. Sia, Z. M. Look, J. S. Barone, S. J. Forbes, A. I. Weiss & B. M. Silber: Bioequivalency of solid oral dosage forms of cefixime. Int. J. Pharmaceutics 1988, 43, 53-58.
6. Falkowski, A. J., Z. M. Look, H. Noguchi & B. M. Silber: Determination of cefixime in biological samples by reversed phase high performance liquid chromatography. J. Chromatogr. 1987, 422, 145-152.
7. Guglielmo, B. J. & G. F. Brooks: Antimicrobial therapy: cost-benefit considerations. Drugs 1989, 38, 473-480.
8. Hussar, D. A.: Importance of patient compliance in effective antimicrobial therapy. Pediatr. Infect. Dis. J. 1987, 6, 971-975.
9. Kamimura, T., H. Kojo, Y. Matsumoto, Y. Mine, S. Goto & S. Kowahara: In vitro and in vivo antibacterial properties of FK027, a new orally active cephem antibiotic. Antimicrob. Agents Chemotherap. 1985, 25, 98-104.
10. Kearns, G. L. & M. D. Reed: Clinical pharmacokinetics in infants and children: a reappraisal. Clin. Pharmacokin. 1989, 17, 29-67.
11. Kearns, G. L., M. D. Reed, R. F. Jacobs, M. Ardite, R. D. Yogev & J. L. Blumer: Single-dose pharmacokinetics of ceftibuten (SCH 39720) in infants and children. Antimicrob. Agents Chemotherap. 1991, 35, 2078-2084.
12. Neu, H. C., N. X. Chin & P. Labthavikul: Comparative in vitro activity and beta-lactamase stability of FR-17027, a new orally active cephalosporin. Antimicrob. Agents Chemotherap. 1984, 26, 174-180.
13. Pfeffer, M., A. Jackson, J. Ximenes & J. Peche de Menedes: Comparative human oral clinical pharmacology of cefadroxil, cephalexin and cephradine. Antimicrob. Agents Chemotherap. 1977, 11, 331-338.
14. Risser, W. L., J. S. Barone, P. A. Clark & D. L. Simpkins: Noncomparative. open label, multicenter trial of cefixime for treatment of bacterial pharyngitis, cystitis and pneumonia in pediatric patients. Pediatr. Infect. Dis. J. 1987, 6, 1002-1006.
15. Rowland, M., & T. M. Tozer: Clinical pharmacokinetics: concepts and applications, 2nd ed. Lea & Febiger, 1989, London.
16. Tally, F. P., K. Cartwright, R. E. Desjardins & E. F. Mccarthy: Safety profile of cefixime. Pediatr. Infect. Dis. J. 1987, 6, 976-980.